Submitted by: Edward Moore
This successful treatment is happening at the same time many congressional representatives are playing politics in favor of the vaccine; downplaying the effective anti-viral treatment and therapeutic approach with Ivermectin; and taking action to block regular American citizens from seeking similar treatment with Ivermectin.
Congress can seek treatment with a medication they simultaneously deny to others? This is well beyond a “scandal”, and needs to be investigated quickly.
Additionally, as Merck has announced a new and similar anti-viral drug called Molnupiravir, two trial studies in India have requested to exit the trials. Apparently the issue surrounds the new drug providing no benefit once a patient is moderately ill and hospitalized (READ MORE, Reuters Link).
Dr. John Campbell highlights a comparison between Ivermectin and Molnupiravir below:
No comments:
Post a Comment